Peptide Therapy Blog
Evidence-based guides and the latest research on peptide therapy, independently researched and editorially reviewed for patients who want to make informed decisions. See our editorial policy for sourcing standards.
Peptide Legal Status Tracker: Where Every Major Peptide Stands With the FDA
A maintained reference for the compounding and approval status of every major peptide — FDA-approved, permitted for compounding, restricted under Category 2, or in regulatory limbo. Updated as the FDA acts on the July 2026 advisory recommendations.
The FDA Is Ending Mass-Compounded Semaglutide and Tirzepatide: What Patients Should Do Now
The shortage exemption that made cheap compounded GLP-1s possible has closed, and the FDA has proposed removing semaglutide and tirzepatide from the 503B bulks list. Here is what remains legal, what your monthly cost is likely to become, and how to plan a transition without losing progress.
Is BPC-157 Legal in 2026? The Complete, Current Answer
BPC-157 left the FDA's restricted list in April 2026 and won a divided advisory committee vote in July. Neither event made it legal to compound. Here is exactly where BPC-157 stands, why the answer is so confusing, and what it means for patients and clinics.
The FDA Peptide Vote, Explained: What Actually Happened on July 23-24 — and What Didn't
FDA's Pharmacy Compounding Advisory Committee recommended 6 of 7 peptides for the 503A Bulks List, overruling FDA's own scientists. Nothing became legal, approved, or available. Here is what the vote actually did, the narrow indications FDA reviewed, and what has to happen next.
Peptide Therapy for Beginners: Everything You Need to Know Before Your First Appointment
The ultimate beginner's guide to peptide therapy covering what peptides are, how they work, major treatment categories, what to expect at your first appointment, timelines for results, costs, and how to find the right provider.
Peptide Therapy Side Effects: An Honest Guide to Risks, Safety, and What to Watch For
An honest, comprehensive guide to peptide therapy side effects covering GLP-1 agonists, growth hormone peptides, BPC-157, drug interactions, quality risks, and how to monitor your health during treatment.
How to Find a Qualified Peptide Therapy Provider: What to Look For and What to Avoid
A comprehensive guide to finding a qualified peptide therapy provider, including credentials to verify, red flags to watch for, and how to use a directory to compare clinics and practitioners.
Are Peptides FDA Approved? The Complete Regulatory Guide for 2026
A comprehensive guide to peptide regulation in 2026, covering which peptides are FDA-approved, the 2025-2026 reclassification of 14 peptides, the July 2026 PCAC vote on BPC-157 and five other peptides, compounding pharmacy rules, and how to verify that your provider and pharmacy are operating legally.
Peptide Therapy Cost in 2026: A Complete Pricing Breakdown by Peptide Type
A detailed guide to peptide therapy costs in 2026, covering GLP-1 agonists, growth hormone peptides, healing peptides, insurance coverage, and how to find affordable providers without sacrificing quality or safety.
Stay Updated
Get notified when new peptide therapy providers join in your area.